Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)

Ruth Dobson; Matthew Craner; Ed Waddingham; Aleisha Miller; Jayant Pindoria; Ana Cavey; Camilla Blain; Luca G De; Nikos Evangelou; Helen Ford; Paul Gallagher; Katila George; Ramos Dias R Geraldes; Paula Harman; Jeremy Hobart; Tanya King; Ruth Linighan; Niall MacDougall; Monica Marta; Stephanie Mitchell; Richard Nicholas; David Rog; Antonio Scalfari; Neil Scolding; Stewart Webb; Sarah White; Judith Wilton; Carolyn Young; Paul M. Matthews

doi:10.1016/j.msard.2022.103894

Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)

Ruth Dobson^*
, Matthew Craner
, Ed Waddingham
, Aleisha Miller
, Jayant Pindoria
, Ana Cavey
, Camilla Blain
, Luca G De
, Nikos Evangelou
, Helen Ford
, Paul Gallagher
, Katila George
, Ramos Dias R Geraldes
, Paula Harman
, Jeremy Hobart
, Tanya King
, Ruth Linighan
, Niall MacDougall
, Monica Marta
, Stephanie Mitchell

Richard Nicholas, David Rog, Antonio Scalfari, Neil Scolding, Stewart Webb, Sarah White, Judith Wilton, Carolyn Young, Paul M. Matthews

^*Corresponding author for this work

Peninsula Medical School

Queen Mary University of London
Royal London Hospital
Frimley Health NHS Foundation Trust
John Radcliffe Hospital
Imperial College London
St George's Hospital
Nottingham University Hospitals NHS Trust
Leeds Teaching Hospitals NHS Trust
Queen Elizabeth University Hospital, Glasgow
Southend Hospital
University Hospitals Plymouth NHS Trust
Institute of Neurological Sciences
NHS Lanarkshire
Northern Care Alliance NHS Group
Charing Cross Hospital
Southmead Hospital NHS Trust
University of Bristol
The Walton Centre NHS Foundation Trust

Research output: Contribution to journal › Article › peer-review

45 Downloads (Pure)

Original language	English
Number of pages	0
Journal	Multiple Sclerosis and Related Disorders
Volume	63
Issue number	0
Early online date	27 May 2022
DOIs	https://doi.org/10.1016/j.msard.2022.103894
Publication status	Published - Jul 2022

Access to Document

10.1016/j.msard.2022.103894

1-s2Final published version, 2.18 MB

Cite this

Dobson, R., Craner, M., Waddingham, E., Miller, A., Pindoria, J., Cavey, A., Blain, C., De, L. G., Evangelou, N., Ford, H., Gallagher, P., George, K., Geraldes, R. D. R., Harman, P., Hobart, J., King, T., Linighan, R., MacDougall, N., Marta, M., ... Matthews, P. M. (2022). Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS). Multiple Sclerosis and Related Disorders, 63(0). https://doi.org/10.1016/j.msard.2022.103894

@article{3b36906fe361456798034889216eca84,

title = "Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)",

author = "Ruth Dobson and Matthew Craner and Ed Waddingham and Aleisha Miller and Jayant Pindoria and Ana Cavey and Camilla Blain and De, \{Luca G\} and Nikos Evangelou and Helen Ford and Paul Gallagher and Katila George and Geraldes, \{Ramos Dias R\} and Paula Harman and Jeremy Hobart and Tanya King and Ruth Linighan and Niall MacDougall and Monica Marta and Stephanie Mitchell and Richard Nicholas and David Rog and Antonio Scalfari and Neil Scolding and Stewart Webb and Sarah White and Judith Wilton and Carolyn Young and Matthews, \{Paul M.\}",

year = "2022",

month = jul,

doi = "10.1016/j.msard.2022.103894",

language = "English",

volume = "63",

journal = "Multiple Sclerosis and Related Disorders",

issn = "2211-0348",

publisher = "Elsevier B.V.",

number = "0",

}

Dobson, R, Craner, M, Waddingham, E, Miller, A, Pindoria, J, Cavey, A, Blain, C, De, LG, Evangelou, N, Ford, H, Gallagher, P, George, K, Geraldes, RDR, Harman, P, Hobart, J, King, T, Linighan, R, MacDougall, N, Marta, M, Mitchell, S, Nicholas, R, Rog, D, Scalfari, A, Scolding, N, Webb, S, White, S, Wilton, J, Young, C & Matthews, PM 2022, 'Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)', Multiple Sclerosis and Related Disorders, vol. 63, no. 0. https://doi.org/10.1016/j.msard.2022.103894

TY - JOUR

T1 - Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)

AU - Dobson, Ruth

AU - Craner, Matthew

AU - Waddingham, Ed

AU - Miller, Aleisha

AU - Pindoria, Jayant

AU - Cavey, Ana

AU - Blain, Camilla

AU - De, Luca G

AU - Evangelou, Nikos

AU - Ford, Helen

AU - Gallagher, Paul

AU - George, Katila

AU - Geraldes, Ramos Dias R

AU - Harman, Paula

AU - Hobart, Jeremy

AU - King, Tanya

AU - Linighan, Ruth

AU - MacDougall, Niall

AU - Marta, Monica

AU - Mitchell, Stephanie

AU - Nicholas, Richard

AU - Rog, David

AU - Scalfari, Antonio

AU - Scolding, Neil

AU - Webb, Stewart

AU - White, Sarah

AU - Wilton, Judith

AU - Young, Carolyn

AU - Matthews, Paul M.

PY - 2022/7

Y1 - 2022/7

UR - https://pearl.plymouth.ac.uk/pms-research/567/

U2 - 10.1016/j.msard.2022.103894

DO - 10.1016/j.msard.2022.103894

M3 - Article

SN - 2211-0348

VL - 63

JO - Multiple Sclerosis and Related Disorders

JF - Multiple Sclerosis and Related Disorders

IS - 0

ER -

Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)

Access to Document

Other files and links

Cite this